Delivery Order SPE2DE24D0013-SPE2D625F0PXP
Award Date 8/8/25
Potential Completion Date 8/15/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This delivery order, awarded on July 24, 2025, represents a $17,680 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc. for a COVID-19/Influenza/RSV diagnostic kit containing 10 viral tests. The contract is set to be completed by July 31, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This award is issued without a set-aside designation and falls under Cepheid's existing indefinite delivery...
- The Defense Department's Medical Supply Chain division awarded Cepheid Inc. a $17,952 firm fixed-price delivery order on August 4, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is set to be completed by August 18, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the Defense Department's reliance on Cepheid's GeneXpert...
- The Defense Logistics Agency Medical Supply Chain awarded a $10.2K firm fixed-price delivery order to Cepheid Inc. on July 22, 2025, for the XpertXpress COVID-19, Influenza, RSV, and Molecular Biology test kit. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, will perform the work at its California facility. This delivery order carries no set-aside designation and represents a continuation of Cepheid's long-standing relationship supplying diagnostic...
- The Defense Logistics Agency awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, with an ultimate completion date of August 15, 2025, was awarded on August 8, 2025, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits, will perform the work at its California...
- The Defense Department's Medical Supply Chain awarded an $14.55K firm fixed-price delivery order to Cepheid Inc. on August 1, 2025, for molecular diagnostic solutions supporting COVID-19, influenza, and respiratory syncytial virus (RSV) testing capabilities. The contract, with an ultimate completion date of August 8, 2025, represents a delivery order against Cepheid's existing federal contract vehicles and carries no set-aside designation. Performance will be executed at Cepheid's headquarters...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $13,096.80 to Cepheid Inc. on July 28, 2025, for molecular diagnostic testing solutions. This firm fixed-price delivery order, designated 4568920464 and titled XPCOV2/FLU/RSV-10, carries an ultimate completion date of August 11, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The contract involves diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $14,960 by the Defense Department's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 21, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions, specifically molecular reagents and assays for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. This award carries...
- The U.S. Department of Defense Medical Supply Chain awarded a $13,600 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. This delivery order, issued on August 7, 2025, with an ultimate completion date of August 14, 2025, represents a continuation of Cepheid's established role as a primary supplier of advanced diagnostic systems and test kits to federal healthcare entities. The...